Author/year | Surgery | Preincisional analgesia | Surgical analgesia | Supplemental postoperative analgesia | Cannabinoid characteristics | |||
Compound | Dose and route of administration | Timing of administration | ||||||
Preoperative regimen | Postoperative regimen | |||||||
Randomized trials | ||||||||
Jain et al (1981)29 | Acute fracture or trauma | N/S | N/S | N/S | Levonantradol | Dose range 1.5 to 3 mg IM; started with lower dose and escalating for subsequent patients | 1 dose (time N/S) | N/A |
Guillaud et al (1983)14 | Renal surgery | N/S | N/S | Noramidopyrine, Camylofine | Levonantradol | 1 mg or 2 mg IM | N/A | 1 dose when fully awake in recovery room |
Buggy et al (2003)13 | Elective abdominal hysterectomy | N/S | 0.1–0.2 mg/kg Morphine | Morphine PCA | −9-Tetrahydrocannabinol | 5 mg PO capsule | N/A | 1 dose on postoperative day 2 |
Beaulieu (2006)26 | Various major surgeries* | N/S | 2mcg/kg Fentanyl | Morphine PCA | Nabilone | 1 mg or 2 mg PO capsule | 1 dose 1 hour prior to GA induction | 1 dose q8h for 24 hours |
Seeling et al (200634 | Radical prostatectomy | N/S | 0.2–0.3 mg Fentanyl; Remifentanil infusion | Piritramide PCA | −9-Tetrahydrocannabinol | 5 mg PO capsule | 1 dose evening before surgery | 7 doses (time N/S) until 48 hours postoperative period |
Ostenfeld et al (2011)33 | Dental extraction | None | None | 500 mg Paracetamol, 15 mg Codeine phosphate | GW842166 (Cannabinoid Receptor-2 Agonist) | 100 mg or 800 mg PO capsule | 1 dose 1 hour prior to surgery | N/A |
Kalliomaki et al (2013)31 | Dental extraction | N/S | N/S | 1000 mg Acetaminophen | AZD1940 (Cannabinoid Receptor-1 and 2 Agonist) | 800mcg PO liquid | 1 dose 1.5 hours prior to surgery | N/A |
Levin et al (2017)32 | Various elective surgeries | N/S | N/S | N/S | Nabilone | 0.5 mg PO capsule | 1 dose (N/S time) prior to GA induction | N/A |
Qualitative trials | ||||||||
Holdcroft et al (2006)28 | Various major surgeries* | N/S | N/S | Morphine PCA | −9-Tetrahydrocannabinol and Cannabidiol extract | Dose range 5 to 15 mg PO capsule; started with lower dose and escalating for subsequent patients | N/A | 1 dose after stopping PCA in post-operative period |
Hickernell et al (2018)27 | Total joint arthroplasty | N/S | N/S | 10 mg Oxycodone q12h×3 doses, 975 mg Acetaminophen q8h, 30 mg or 15 mg Ketorolac q6h×4 doses, 200 mg Gabapentin two times a day, 200 mg Celecoxib q12h | Dronabinol | 5 mg PO capsule | N/A | 2 doses daily until day of discharge |
Liu et al (2018)35 | Major orthopedic surgery | N/S | N/S | N/S | Nabilone; Cannabis; Cannabinoid oil | N/S dose; PO capsule/ inhaled/ oils | Chronic user | N/S |
Jennings et al (2019)30 | Total knee arthroplasty | N/S | N/S | N/S | Cannabis | N/S dose; PO capsule/ inhaled | Chronic user | N/S |
*Major surgeries included orthopedic, gynecologic, urology, plastics, and general.
GA, general anesthesia; IM, intramuscular; N/A, not applicable; N/S, not specified; PCA, patient-controlled analgesia; PO, per oral; q, every.